We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-10.54%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$129B
AUM Growth
-$14.8B
Cap. Flow
+$5.69B
Cap. Flow %
4.39%
Top 10 Hldgs %
31.86%
Holding
7,834
New
489
Increased
2,471
Reduced
3,566
Closed
777

Sector Composition

Rank Sector Weight
1 Technology 6.9%
2 Healthcare 5.31%
3 Financials 5.25%
4 Communication Services 4.61%
5 Consumer Discretionary 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFG icon
5301
PUT
Principal Financial Group
PFG
$24.3B
$57K ﹤0.01%
1,300
-3,100
-70% -$153K
MRNS
5302
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$57K ﹤0.01%
5,000
TGH
5303
DELISTED
Textainer Group Holdings limited
TGH
$57K ﹤0.01%
5,678
-16,604
-75% -$185K
PS
5304
PUT
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$57K ﹤0.01%
+2,400
New +$55.3K
AIMT
5305
DELISTED
Aimmune Therapeutics
AIMT
$57K ﹤0.01%
2,375
-62,153
-96% -$1.61M
AVP
5306
CALL
DELISTED
Avon Products, Inc.
AVP
$57K ﹤0.01%
37,600
+18,600
+98% +$35.6K
FBR
5307
DELISTED
Fibria Celulose Sa
FBR
$57K ﹤0.01%
+3,289
New +$60.6K
ADVM
5308
DELISTED
Adverum Biotechnologies
ADVM
$56K ﹤0.01%
1,786
-5,128
-74% -$209K
OLP
5309
One Liberty Properties
OLP
$517M
$56K ﹤0.01%
2,298
-5,959
-72% -$154K
UBS icon
5310
CALL
UBS Group
UBS
$176B
$56K ﹤0.01%
4,500
+2,500
+125% +$33.9K
WATT icon
5311
PUT
Energous
WATT
$104M
$56K ﹤0.01%
16
-38
-70% -$185K
WSO icon
5312
CALL
Watsco Inc
WSO
$13.3B
$56K ﹤0.01%
+400
New +$61K
XONE
5313
DELISTED
The ExOne Company
XONE
$56K ﹤0.01%
8,508
+8,138
+2,199% +$65.5K
JAX
5314
DELISTED
J. Alexander's Holdings, Inc.
JAX
$56K ﹤0.01%
6,841
-5,961
-47% -$58.7K
GOLF icon
5315
Acushnet Holdings
GOLF
$5.35B
$55K ﹤0.01%
2,605
-15,355
-85% -$366K
NCLH icon
5316
CALL
Norwegian Cruise Line
NCLH
$8.58B
$55K ﹤0.01%
+1,300
New +$63K
SIGA icon
5317
SIGA Technologies
SIGA
$208M
$55K ﹤0.01%
6,942
-13,787
-67% -$78.8K
UPBD icon
5318
CALL
Upbound Group
UPBD
$1.12B
$55K ﹤0.01%
3,400
+2,100
+162% +$30.5K
PDCO
5319
CALL
DELISTED
Patterson Companies, Inc.
PDCO
$55K ﹤0.01%
2,800
+1,700
+155% +$39.7K
GTHX
5320
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$55K ﹤0.01%
2,855
-17,515
-86% -$656K
ERF
5321
CALL
DELISTED
Enerplus Corporation
ERF
$55K ﹤0.01%
7,100
+5,100
+255% +$49.6K
LGCY
5322
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$55K ﹤0.01%
35,897
+33,900
+1,698% +$109K
ADNT icon
5323
CALL
Adient
ADNT
$1.47B
$54K ﹤0.01%
3,600
+700
+24% +$18.1K
BANF icon
5324
BancFirst
BANF
$3.82B
$54K ﹤0.01%
1,073
-6,873
-86% -$383K
CNP icon
5325
PUT
CenterPoint Energy
CNP
$26.5B
$54K ﹤0.01%
1,900
-1,700
-47% -$47.4K

Similar funds

Barclays's Q4 2018 Portfolio in Review

As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.

  • Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
  • Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
  • Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
  • Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
  • Barclays opened 489 new positions and closed 777 in Q4 2018.
  • Barclays's portfolio value fell 10% quarter-over-quarter to $129B.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.